First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (neo)adjuvant trastuzumab

被引：0
|
作者：
Vaglica, M. [1 ]
Lambertini, M. [2 ]
Ferreira, A. [3 ]
Poggio, F. [2 ]
Puglisi, F. [4 ]
Sottotetti, F. [5 ]
Montemurro, F. [6 ]
Poletto, E. [4 ]
Pozzi, E. [5 ]
Risi, E. [7 ]
Lai, A. [8 ]
Zanardi, E. [9 ]
Sini, V. [10 ]
Ziliani, S. [11 ]
Minuti, G. [12 ]
Mura, S. [13 ]
Grasso, D. [14 ]
Ferrarini, I. [15 ]
Pronzato, P. [2 ]
Del Mastro, L. [1 ]
机构：
[1] IRCCS AOU San Martino IST, Med Oncol, UO Sviluppo Terapie Innovat, Genoa, Italy
[2] IRCCS AOU San Martino IST, UO Oncol Med 2, Genoa, Italy
[3] Hosp Santa Maria, Inst Med Mol, Lisbon, Portugal
[4] Univ Hosp, Oncol, Udine, Italy
[5] Fdn Maugeri IRCCS, Med Oncol, Pavia, Italy
[6] Fdn Piemonte Oncol, Ist Candiolo IRCCS, Unit Invest Clin Oncol, Candiolo Torino, Italy
[7] Univ Roma La Sapienza, Radiol Oncol & Human Pathol, Oncol Unit B, I-00185 Rome, Italy
[8] Azienda Osped Univ, Med Oncol, Sassari, Italy
[9] IRCCS AOU San Martino IST, Med Oncol, Clin Oncol Med, Genoa, Italy
[10] Univ Roma La Sapienza, St Andrea Hosp, Oncol, I-00185 Rome, Italy
[11] Osped San Paolo, Med Oncol, Savona, Italy
[12] Civil Hosp, Ist Tumori Toscano, Med Oncol, Livorno, Italy
[13] Osped Santissima Annunziata, Oncol, Sassari, Italy
[14] IRCCS San Matteo Univ Hosp Fdn, Med Oncol, Pavia, Italy
[15] Azienda Osped Univ Pisana, Polo Oncol, Pisa, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)30813-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1863
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [41] Oral vinorelbine in combination with trastuzumab as a first line therapy of metastatic or locally advanced HER2-positive breast cancer
    Ghosn, M.
    Kattan, J.
    Chahine, G.
    Makdessi, J.
    Bitar, N.
    El-Mouhebb, M.
    Mourad, C.
    Farhat, F.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S182 - S183
  • [42] Neratinib after trastuzumab in patients with HER2-positive breast cancer
    Hasegawa, Takahiro
    Uno, Hajime
    Wei, Lee-Jen
    LANCET ONCOLOGY, 2016, 17 (05): : E176 - E176
  • [43] Presentation and treatment of HER2-positive metastatic breast cancer patients already treated with adjuvant trastuzumab
    Yuri Torrejon, Davis
    Di Cosimo, Serena
    Sanchez-Olle, Gessami
    Balmana, Judith
    Bellet, Meritxell
    Gomez, Patricia
    Saura, Cristina
    Manuel Perez-Garcia, Jose
    Munoz-Couselo, Eva
    Vidal, Maria
    Ortega, Vanesa
    De Mattos-Arruda, Leticia
    Oliveira, Mafalda
    Mulet-Margalef, Nuria
    Tabernero, Josep
    Cortes, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] ORAL VINORELBINE IN COMBINATION WITH TRASTUZUMAB AS A FIRST LINE THERAPY OF METASTATIC OR LOCALLY ADVANCED HER2-POSITIVE BREAST CANCER
    Farhat, Fadi
    Kattan, Joseph
    Ghosn, Marwan
    BREAST, 2015, 24 : S42 - S43
  • [45] Oral vinorelbine in combination with trastuzumab as a first line therapy of metastatic or locally advanced Her2-positive breast cancer
    Farhat, F.
    Kattan, J.
    Chahine, G.
    Makdessi, J.
    Bitar, N.
    Ghosn, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S281 - S281
  • [46] Effect of Adjuvant/Neoadjuvant Trastuzumab on Clinical Outcomes in Patients With HER2-Positive Metastatic Breast Cancer
    Murthy, Rashmi K.
    Varma, Ankur
    Mishra, Priyankana
    Hess, Kenneth R.
    Young, Elliana
    Murray, James L.
    Koenig, Kimberly H.
    Moulder, Stacy L.
    Melhem-Bertrandt, Amal
    Giordano, Sharon H.
    Booser, Daniel
    Valero, Vicente
    Hortobagyi, Gabriel N.
    Esteva, Francisco J.
    CANCER, 2014, 120 (13) : 1932 - 1938
  • [47] Rechallenge of trastuzumab-based therapy in HER2-positive breast cancer patients who progressed after lapatinib plus capecitabine
    Khanmammadov, Nijat
    Dogan, Izzet
    Khishigsuren, Bayarmaa
    Azizy, Abdulmunir
    Saip, Pinar
    Aydiner, Adnan
    MEDICINE, 2025, 104 (06)
  • [48] Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure
    Antonarelli, G.
    Corti, C.
    Salimbeni, B. T.
    Tarantino, P.
    Zagami, P.
    Marra, A.
    Trapani, D.
    Tolaney, S.
    Cortes, J.
    Curigliano, G.
    ESMO OPEN, 2023, 8 (04)
  • [49] EVALUATION OF TRASTUZUMAB FOR ADJUVANT THERAPY OF HER2-POSITIVE BREAST CANCER EGYPTIAN FEMALES
    Abbas, N. A. R.
    ANNALS OF ONCOLOGY, 2010, 21 : 44 - 44
  • [50] Lapatinib-based therapy in heavily pretreated HER2-positive metastatic breast cancer: a single institution experience
    Crivellari, Diana
    Spazzapan, Simon
    Lombardi, Davide
    Militello, Loredana
    Torrisi, Elena
    Russo, Alessia E.
    Sorio, Roberto
    Talamini, Renato
    Miolo, Gianmaria
    Carli, Paolo
    Veronesi, Andrea
    TUMORI JOURNAL, 2012, 98 (01): : 33 - 38
12345